Telo Genomics (Germany) Today
| 3D0A Stock | EUR 0.04 0.01 28.57% |
Performance5 of 100
| Odds Of DistressOver 63
|
Telo Genomics is trading at 0.035 as of the 24th of November 2024. This is a 28.57% down since the beginning of the trading day. The stock's lowest day price was 0.035. Telo Genomics has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Telo Genomics Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 24th of November 2024. Click here to learn more.
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada. The company has 59.42 M outstanding shares. More on Telo Genomics Corp
Moving against Telo Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Telo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Telo Genomics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Telo Genomics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Telo Genomics Corp (3D0A) is traded on Frankfurt Exchange in Germany and employs 10 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telo Genomics's market, we take the total number of its shares issued and multiply it by Telo Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Telo Genomics Corp operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 59.42 M outstanding shares.
Telo Genomics Corp has accumulated about 1.96 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Telo Genomics Probability Of Bankruptcy
Ownership AllocationTelo Genomics Corp shows a total of 59.42 Million outstanding shares. Telo Genomics Corp has 6.52 % of its outstanding shares held by insiders and 1.83 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Telo Ownership Details
Telo Genomics Corp Risk Profiles
Although Telo Genomics' alpha and beta are two of the key measurements used to evaluate Telo Genomics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 21.1 | |||
| Semi Deviation | 21.51 | |||
| Standard Deviation | 29.2 | |||
| Variance | 852.55 |
Telo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Telo Genomics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Telo Genomics Corporate Executives
Elected by the shareholders, the Telo Genomics' board of directors comprises two types of representatives: Telo Genomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telo. The board's role is to monitor Telo Genomics' management team and ensure that shareholders' interests are well served. Telo Genomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telo Genomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sabine Mai | Member Founder | Profile |
Other Information on Investing in Telo Stock
Telo Genomics financial ratios help investors to determine whether Telo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.